increasing incidence of diseases is driving the Infusion Systems Market

Latest News:- Infusion Systems Market: Hospitals is expected to lead the Application segment during 2024-2028

Technavio analyzes that the Infusion Systems Market is expected to grow at a CAGR of 3.8% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1642.6 million.There are various factors that contribute to the growth of the market. The Infusion Systems Market is experiencing significant growth due to the rising prevalence of chronic diseases worldwide. These systems enable the delivery of therapeutic fluids, medications, and nutrients directly into the patient's body, making them an essential component of disease management. The increasing burden of chronic conditions, such as diabetes, cancer, and neurological disorders, is driving the demand for advanced infusion systems. Additionally, the adoption of home healthcare and the growing preference for minimally invasive treatments are further fueling market expansion.

In the healthcare industry, advanced infusion systems have revolutionized intravenous drug delivery, enhancing patient care and reducing medical errors. Cardioprotective drugs, anesthetic agents, and other medications require precise dosage and delivery to ensure optimal patient outcomes. Infusion devices, including electromechanical systems, peristaltic pumps, and gravity feed with in-line pistons, offer accurate and consistent delivery, minimizing the risk of myocardial edema and hemorrhages. Smart infusion pumps, integrated with preprogrammed drug libraries and Dose Error Reduction Systems (DERS), are now the standard in over 80% of US hospitals. These systems enable nurses to input patient-specific information, program infusion rates, and duration, thereby reducing medication errors and improving overall patient care. The implementation of DERS software facilitates real-time monitoring and documentation of drug administration, ultimately boosting clinician productivity and ensuring high-quality patient care within hospital settings. 

Know which region is leading the market growth by requesting a sample report

Infusion Systems Market Segmentation

• Application
  • Hospitals
  • Ambulatory surgical centers
  • Diagnostics centers
  • Others
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

• Avanos Medical Inc.
• B.Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• Epic Medical
• Fresenius Kabi AG
• ICU Medical Inc.
• Insulet Corp.
• JMS North America Corp.
• Medtronic Plc
• Micrel Medical Devices SA
• Moog Inc.
• Nipro Corp.
• Shenzhen MedRena Biotech Co. Ltd.
• Smiths Group Plc
• SOOIL Development Co. Ltd.
• Tandem Diabetes Care Inc.
• Teleflex Inc.
• Terumo Corp.
• Zyno Medical

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The Infusion Systems Market encompasses technologies for delivering various substances, including Peripheral Intravenous Injections, Coronary Artery Injections, and Venous Injections, via Plasmid Vectors and Adenoviral Vectors. These systems employ Vector Dilution for efficient delivery, targeting Systemic Blood Circulation and Cardiotropism. Coronary Venous Blockade and Retrograde Venous Infusion are used for Gene Delivery Methods in treating Heart Failure (HF) and Cardiac Recirculation. Infusion Devices include Electromechanical Systems for delivering Cardioprotective Drugs, Anesthetic Drugs, and addressing conditions like Myocardial Edema, Hemorrhages, Coronary Artery Obstruction, and Atherosclerosis.

Market Research Overview

The Infusion Systems Market is a significant segment of the broader Global Healthcare Supplies Market, focusing on solutions for Peripheral Intravenous Injections, Coronary Artery Injections, Venous Injections, and Myocardial Transductions. Technavio's market analysis calculates the market size based on the consolidated revenue of key players specializing in Infusion Systems, including those utilizing Plasmid Vectors and Adenoviral Vectors, as well as Vector Dilution systems. The market's expansion is anticipated to be influenced by several key factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and Europe's population is projected to be over 60 years old, necessitating increased demand for advanced healthcare solutions and infusion systems.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

• Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.


• Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.


• High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/